Oxford University Explores Ivermectin As COVID-19 Treatment

Must Read

Cory Aquino Admin’s Press Secretary Passes Away

Press secretary during Cory Aquino's admin dies Tomas "Buddy" Gomez III, who once...

DOH Reminds Public To Self-Isolate If Experiencing Flu-like Symptoms Amidst COVID-19 Threat

The DOH reminded the public to self-isolate if they're experiencing flu-like symptoms amidst COVID-19 threat.

Ex-VP Binay to Run for Senator in 2022 Elections

Binay for senator in the upcoming elections JEJOMAR BINAY - The former vice...

Oxford University explored Ivermectin as a COVID-19 treatment

On Wednesday, Oxford University said that it was testing anti-parasitic drug Ivermectin as a possible treatment for coronavirus disease (COVID-19) as part of a British government-backed study that aimed to aid recoveries in non-hospital settings.

Oxford University explored Ivermectin as a COVID-19 treatment
Photo source: ABS-CBN News

The university said that Ivermectin resulted in a reduction of coronavirus replication in laboratory studies, adding that a small pilot showed giving the said drug early could reduce viral load and the duration of coronavirus symptoms in some patients with mild COVID-19.

Dubbed “PRINCIPLE”, Inquirer reported that the British study last January showed that antibiotics doxycycline and azithromycin were generally ineffective against early-stage COVID-19.

While the World Health Organization (WHO), and US and European regulators have recommended against using Ivermectin in COVID-19 patients, it was being used to treat the illness in several countries — including India and the Philippines.

By including ivermectin in a large-scale trial like PRINCIPLE, we hope to generate robust evidence to determine how effective the treatment is against COVID-19, and whether there are benefits or harms associated with its use,” said Chris Butler, a co-lead investigator of the clinical trial.

READ ALSO: President Duterte Wants Speedy Completion Of Study On Efficacy Of Ivermectin vs COVID-19

The university added that people with severe liver conditions, who were on blood-thinning medication warfarin, or taking other treatments known to interact with ivermectin, will be excluded from the clinical trial.

Moreover, the university said that Ivermectin was the seventh treatment to be investigated in the clinical trial and was currently being evaluated alongside antiviral drug favipiravir.

Meanwhile, President Rodrigo Duterte said last week that he wanted the speedy completion of the study on the efficacy of Ivermectin against the coronavirus disease.

For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

Cory Aquino Admin’s Press Secretary Passes Away

Press secretary during Cory Aquino's admin dies Tomas "Buddy" Gomez III, who once...

DOH Reminds Public To Self-Isolate If Experiencing Flu-like Symptoms Amidst COVID-19 Threat

The DOH reminded the public to self-isolate if they're experiencing flu-like symptoms amidst COVID-19 threat. On Saturday, the...

Ex-VP Binay to Run for Senator in 2022 Elections

Binay for senator in the upcoming elections JEJOMAR BINAY - The former vice president will run for senator...

Robi Domingo Reacts to Kapamilya Stars Transferring to GMA-7, TV5

Robi Domingo: "Siyempre nakakalungkot na sa ganitong pagkakataon." Robi Domingo respects the decision of the former Kapamilya stars...

Joshua Garcia Open To Try Other Business Ventures, To Focus On Academy of Rock

Joshua Garcia shared that he's open to try other business ventures. Actor Joshua Garcia recently shared that he's...

More Articles Like This